According to Zacks Investment Research, "HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development. Find the latest HTG Molecular Diagnostics, Inc. (HTGM) stock quote, history, news and other vital information to help you with your stock trading and investing. HTGM | Complete HTG Molecular Diagnostics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. HTGM HTG Molecular Diagnostics, Inc. Common Stock. Data is currently not available. $0.5299. 0.0476 (8.24%) DATA AS OF May 29, 2020. Our vendor, Zacks Investment Research, hasn't provided us

HTG Molecular Diagnostics Inc (NASDAQ:HTGM) released its earnings results on Wednesday, May, 13th. The medical research company reported ($0.08) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.09) by $0.01.

HTG Molecular Diagnostics Inc. company facts, information and stock details by MarketWatch. View htgm business summary and other industry information. HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates. HTG Molecular Diagnostics Inc (HTGM) delivered earnings and revenue surprises of 0.00% and -2.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock? Zacks Investment Research | May 13, 2020 4 Wall Street analysts have issued ratings and price targets for HTG Molecular Diagnostics in the last 12 months. Their average twelve-month price target is $1.18, suggesting that the stock has a possible upside of 113.64%. The high price target for HTGM is $1.50 and the low price target for HTGM is $0.70.

Stock News - TD Ameritrade

HTG Molecular Diagnostics News | Markets Insider Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline Zacks 47d HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on HTG Molecular Diagnostics, Inc. (HTGM) Interactive Stock ... HTG Molecular Diagnostics Inc (HTGM) delivered earnings and revenue surprises of 0.00% and -2.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock? HTG Molecular Diagnostics Inc (HTGM) doesn't possess the right combination of the two key HTG Molecular Diagnostics - Stock Price History | HTGM ...

According to Zacks Investment Research, "HTG Molecular Diagnostics, Inc. is engaged in developing and marketing a technology platform which consists of instrumentation, consumables and software analytics for sample profiling applications including tumor profiling, molecular diagnostic testing and biomarker development.

HTGM - HTG Molecular Summary, Stock Quote and News | Benzinga HTG Molecular (NASDAQ: HTGM) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. HTG Molecular Diagnostics (NASDAQ:HTGM) Raised to Hold at ...

Get the latest HTG Molecular Diagnostics, Inc. (HTGM) stock news and headlines to help you in your trading and investing decisions.

In this article you are going to find out whether hedge funds think HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) is a good investment right now. We like to check what the smart money thinks first HTG Molecular Diagnostics Inc. company facts, information and stock details by MarketWatch. View htgm business summary and other industry information. HTG Molecular Diagnostics Inc (HTGM) Reports Q1 Loss, Misses Revenue Estimates. HTG Molecular Diagnostics Inc (HTGM) delivered earnings and revenue surprises of 0.00% and -2.41%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock? Zacks Investment Research | May 13, 2020 4 Wall Street analysts have issued ratings and price targets for HTG Molecular Diagnostics in the last 12 months. Their average twelve-month price target is $1.18, suggesting that the stock has a possible upside of 113.64%. The high price target for HTGM is $1.50 and the low price target for HTGM is $0.70.

• tiempo de comercio de crudo mcx
• cách tốt nhất để đầu tư ngắn hạn 10k
• trader role xp
• tabla de asientos para jetblue airbus a320
• best mortgage interest rates in bc
• pgwurhi
• pgwurhi
• pgwurhi